- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : HFIT
총 559 건
-
Universitätsmedizin MannheimBaden-Württemberg Stiftung gGmbH완전한
-
The Greater Poland Cancer Centre모집하지 않고 적극적으로
-
Parc de Salut Mar완전한
-
Bangkok Metropolitan Administration Medical College...완전한
-
Instituto Nacional de Ciencias Medicas y Nutricion...Conquer Cancer Foundation모병
-
Klinik ValensState Secretariat for Education Research and Innovation, Switzerland; Office Ambient Assisted...완전한
-
Genzyme, a Sanofi Company완전한
-
University of New MexicoUniversity of Massachusetts, Worcester완전한알코올 사용 장애
-
Ankara City Hospital BilkentAtaturk University; Kutahya Health Sciences University; Fatih Sultan Mehmet Training and... 그리고 다른 협력자들모병
-
Yonsei University알려지지 않은
-
M.D. Anderson Cancer CenterOSI Pharmaceuticals종료됨
-
Pharmacosmos A/S완전한
-
AstraZeneca완전한
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science University모집하지 않고 적극적으로
-
M.D. Anderson Cancer CenterOSI Pharmaceuticals완전한
-
Hip Innovation Technology모병
-
Pharmacosmos A/S완전한
-
Swiss Tropical & Public Health InstituteUniversity of Applied Sciences and Arts Northwestern Switzerland; Terre des Hommes모병
-
Lewai Sharki Abdulaziz, MSc PhDAl-Kindy College of Medicine; Research & Development Directorate, Ministry of Higher Education...완전한
-
Southwest Oncology GroupNational Cancer Institute (NCI)완전한
-
Ohio State University Comprehensive Cancer CenterNational Institute on Aging (NIA)완전한
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)완전한Blast Phase 만성 골수성 백혈병, BCR-ABL1 양성 | 재발성 만성 골수성 백혈병, BCR-ABL1 양성 | 난치성 만성 골수성 백혈병, BCR-ABL1 양성 | 골수 유핵 세포의 5% 이상 파괴 | B 급성 림프구성 백혈병 t(9;22)(q34.1;q11.2); BCR-ABL1 | CD22 포지티브 | 필라델피아 염색체 양성, BCR-ABL1 양성 만성 골수성 백혈병미국
-
Central Hospital, Nancy, France완전한헤파린 유발 혈소판 감소증
-
National Institute of Allergy and Infectious Diseases...빼는